ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/2/2025ACC: 0001415889-25-019059
Officer· Interim CFO
Since Jun 2021
-3.42K
Net shares
Net seller
$5.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.42K
Price / share
$1.65
Trade value
$5.64K
% of position
2.9%
6/30/2025
118.49K→115.07K
Total
Net shares
−3.42K
Net value
-$5.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | F · Tax Withholding | −3.42K | $1.65 | $5.64K | 2.9% | 118.49K | 115.07K |
| Total | −3.42K | -$5.64K | ||||||
Derivative Transactions0
No derivative transactions reported